A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain

NCT02308020 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Non-small Cell Lung Cancer
Melanoma
Brain Metastases

Interventions

DRUG: Abemaciclib

Sponsor

Eli Lilly and Company